Autopsy report · NCT00823472
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
Cause of deathSlow enrollment
“Inclusion of the study didn't go as fast as expected. Expect: 234 patients in 1 year in 2 centers. After 1,5 year only 147 patients were recruited.”
Life of this trial
- Ran for about 1 year 9 months before it stopped.
- 147 participants enrolled.
- Results were posted on the registry 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- UMC Utrecht
- Sponsor type
- University, hospital or other
- Conditions
- in Vitro Fertilization; Ovulation Induction
- Interventions
- Mild stimulation
- Participants
- 147
- Sites
- 2
- Countries
- Belgium, Netherlands
Trials that died the same way
- Xenogenic Keratoplasty From Porcine Cornea
“there was not enough patients recruited in this study” - Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
“The rate of inclusion is too low to hope to reach the target of 800 patients. 59 patients were included, and their data will not meet the research objectives. The sponsor has decided to prematurely stop inclusions on January 13, 2022.” - Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
“The number of patients enrolled was much less than expected” - Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies
“The study was interrupted early and terminated when only 26 out of 80 patients were enrolled due to new clinical study results indicating that the current study would not be informative.” - Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
“study was stopped after enrolment of about 200 patients for slow recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.